Prevalence and Treatment Patterns of Inflammatory Bowel Disease in the All of Us Research Program.
作者信息
Tracy Michaela S, Challa Prasanna K, Lopes Emily W, Khalili Hamed
机构信息
Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA.
出版信息
Inflamm Bowel Dis. 2024 Aug 1;30(8):1426-1429. doi: 10.1093/ibd/izad170.
Abstract
摘要
相似文献
1
Prevalence and Treatment Patterns of Inflammatory Bowel Disease in the All of Us Research Program.
Inflamm Bowel Dis. 2024 Aug 1;30(8):1426-1429. doi: 10.1093/ibd/izad170.
2
Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.
Inflamm Bowel Dis. 2020 Mar 4;26(4):619-625. doi: 10.1093/ibd/izz182.
3
COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
Inflamm Bowel Dis. 2021 Jun 15;27(7):1166-1169. doi: 10.1093/ibd/izab041.
4
Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.
Dig Dis Sci. 2019 Jul;64(7):1798-1808. doi: 10.1007/s10620-019-05494-w. Epub 2019 Feb 12.
5
Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey.
Environ Pollut. 2017 Oct;229:621-626. doi: 10.1016/j.envpol.2017.06.023.
6
The association between inflammatory bowel disease and migraine or severe headache among US adults: Findings from the National Health Interview Survey, 2015-2016.
Headache. 2021 Apr;61(4):612-619. doi: 10.1111/head.14087. Epub 2021 Mar 23.
7
Another tool in the epidemiologist's toolbox.
Inflamm Bowel Dis. 2006 Mar;12(3):245-6. doi: 10.1097/00054725-200603000-00013.
8
Trends in hospitalizations of children with inflammatory bowel disease within the United States from 2000 to 2009.
J Investig Med. 2013 Aug;61(6):1036-8. doi: 10.2310/JIM.0b013e31829a4e25.
9
Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.
10
Management issues in women with inflammatory bowel disease.
J Am Osteopath Assoc. 2001 Dec;101(12 Suppl Pt 2):S17-23.
本文引用的文献
1
Validity of Diagnostic Algorithms for Inflammatory Bowel Disease in Japanese Hospital Claims Data.
Int J Environ Res Public Health. 2022 Jun 28;19(13):7933. doi: 10.3390/ijerph19137933.
2
Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies.
Clin Gastroenterol Hepatol. 2018 Feb;16(2):190-197.e11. doi: 10.1016/j.cgh.2017.05.047. Epub 2017 Jun 8.
3
Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015.
MMWR Morb Mortal Wkly Rep. 2016 Oct 28;65(42):1166-1169. doi: 10.15585/mmwr.mm6542a3.
4
National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States.
J Crohns Colitis. 2014 Apr;8(4):288-95. doi: 10.1016/j.crohns.2013.09.001. Epub 2013 Sep 24.
5
Racial disparities in utilization of specialist care and medications in inflammatory bowel disease.
Am J Gastroenterol. 2010 Oct;105(10):2202-8. doi: 10.1038/ajg.2010.202. Epub 2010 May 18.
6
Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study.
Inflamm Bowel Dis. 2008 Jan;14(1):13-9. doi: 10.1002/ibd.20298.
Zotero 插件